PF-06409577 Activates AMPK Signaling and Inhibits Osteosarcoma Cell Growth

por Zhu, Yun-Rong, Zhang, Xiang-Yang, Wu, Qiu-Ping, Yu, Cheng-Jian, Liu, Yuan-Yuan, Zhang, Yun-Qing
Publicado 2021

Cosmetics use-related adverse events

por Yang, Su-Lian, Zheng, Yue, Zhang, Yun-Qing, Ye, Cong-Xiu, Yi, Jin-Ling, Liu, Yu-Fang, Lai, Wei
Publicado 2019

Developing Shingles-Induced Koebner Phenomenon in a Patient With Psoriasis: A Case Report

por Zhao, Yu-Kun, Zhang, Yun-Qing, Wang, Fang, Wu, Hui-Hui, Luo, Ze-Yu, Luo, Di-Qing, Chen, Wen-Na
Publicado 2015

The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models

por Zhu, Yun-Rong, Zhou, Xiao-zhong, Zhu, Lun-qing, Yao, Chen, Fang, Jian-Feng, Zhou, Feng, Deng, Xiong-Wei, Zhang, Yun-Qing
Publicado 2016